Lipoxin A4 Stimulates Calcium-Activated Chloride Currents and Increases Airway Surface Liquid Height in Normal and Cystic Fibrosis Airway Epithelia by Verrière, Valia et al.
Lipoxin A4 Stimulates Calcium-Activated Chloride
Currents and Increases Airway Surface Liquid Height in
Normal and Cystic Fibrosis Airway Epithelia
Valia Verrie `re
1., Gerard Higgins
1,4., Mazen Al-Alawi
1,3, Richard W. Costello
3, Paul McNally
4,
Raphae ¨l Chiron
2, Brian J. Harvey
1, Vale ´rie Urbach
1,4*
1Department of Molecular Medicine, RCSI Education and Research Centre, Beaumont Hospital, Dublin, Ireland, 2CRCM, Montpellier, France, 3Department of Respiratory
Medicine, Beaumont Hospital, Dublin, Ireland, 4National Children’s Research Centre, Our Lady’s Children’s Hospital Crumlin, Dublin, Ireland
Abstract
Cystic Fibrosis (CF) is a genetic disease characterised by a deficit in epithelial Cl
2 secretion which in the lung leads to airway
dehydration and a reduced Airway Surface Liquid (ASL) height. The endogenous lipoxin LXA4 is a member of the newly
identified eicosanoids playing a key role in ending the inflammatory process. Levels of LXA4 are reported to be decreased in
the airways of patients with CF. We have previously shown that in normal human bronchial epithelial cells, LXA4 produced a
rapid and transient increase in intracellular Ca
2+. We have investigated, the effect of LXA4 on Cl
2 secretion and the
functional consequences on ASL generation in bronchial epithelial cells obtained from CF and non-CF patient biopsies and
in bronchial epithelial cell lines. We found that LXA4 stimulated a rapid intracellular Ca
2+ increase in all of the different CF
bronchial epithelial cells tested. In non-CF and CF bronchial epithelia, LXA4 stimulated whole-cell Cl
2 currents which were
inhibited by NPPB (calcium-activated Cl
2 channel inhibitor), BAPTA-AM (chelator of intracellular Ca
2+) but not by CFTRinh-
172 (CFTR inhibitor). We found, using confocal imaging, that LXA4 increased the ASL height in non-CF and in CF airway
bronchial epithelia. The LXA4 effect on ASL height was sensitive to bumetanide, an inhibitor of transepithelial Cl
2 secretion.
The LXA4 stimulation of intracellular Ca
2+, whole-cell Cl
2 currents, conductances and ASL height were inhibited by Boc-2, a
specific antagonist of the ALX/FPR2 receptor. Our results provide, for the first time, evidence for a novel role of LXA4 in the
stimulation of intracellular Ca
2+ signalling leading to Ca
2+-activated Cl
2 secretion and enhanced ASL height in non-CF and
CF bronchial epithelia.
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Introduction
Cystic fibrosis is caused by the mutation of the gene coding for
the Cystic Fibrosis Transmembrane conductance Regulator
(CFTR), a cyclic AMP-dependent Cl
2 channel. The major clinical
features of CF are chronic pulmonary disease, exocrine pancreatic
insufficiency and male infertility [1,2]. The lung disease is the
main cause of morbidity and mortality in CF. The airway
epithelium of patients with CF fails to transport Cl
2 and water,
resulting in a reduced ASL height and impaired mucociliary
clearance. The hyper-absorption of Na
+ observed in the CF
bronchial epithelium may further exacerbate the dehydration of
the ASL. It is generally accepted that the dehydration of the
airway lumen favours chronic infection and inflammation leading
to progressive destruction of the lung [3]. Identification of agents,
particularly natural endogenous biologicals, which stimulate
alternative non-CFTR Cl
2 secretory pathways and promote
ASL hydration and recovery of optimal ASL height are likely to be
of therapeutic benefit in improving mucociliary clearance in
patients with CF.
The levels of LXA4 in the airways have been reported to be
decreased in patients with CF [4]. Lipoxins are bioactive lipids
derived from omega-6 polyunsaturated fatty acids and play
important roles in various biological functions [5]. The endoge-
nous lipoxin A4 (LXA4: 5S,6R,15S-trihydroxy-7,9,13-trans-11-
eicosatetraenoic acid) is produced at inflammatory sites from the
interaction of lipoxygenase activities of several cell types including
leukocytes, platelets and epithelial cells. LXA4is one member of
the newly identified lipid molecules playing a role in ending/
resolving the inflammatory process by modulating neutrophilic
inflammation, clearing apoptotic PMN and inhibiting the
production of pro-inflammatory cytokines [6]. The deficit in
LXA4 levels in CF airways could be a contributing factor in
chronic airway inflammation which characterises these patients.
Very little is known about the role of LXA4 in the lung beyond
its anti-inflammatory effects. We have previously shown that
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LXA4. The receptor for LXA4 (ALX/FPR2) is expressed in the
bronchial epithelial cell line 16HBE14o- and LXA4 stimulates an
intracellular Ca
2+ mobilisation in these cells [7]. Intracellular Ca
2+
is a major regulator of Cl
2 transport and the stimulation of
epithelial Cl
2 secretion would be of major therapeutic benefit in
CF to restore efficient airway clearance. We have investigated the
effect of LXA4 on epithelial Cl
2 secretion and its functional
consequences on ASL height using bronchial epithelial cells
obtained from CF and non-CF patient biopsies and in a variety of
bronchial epithelial cell lines commonly used as models for CF ion
transport and immunological studies.
Results
LXA4 Effects on Intracellular Ca
2+ in Normal and CF
Bronchial Epithelial Cells
LXA4 induced a rapid increase of intracellular Ca
2+ in all
human airway epithelial cell types tested. These results are
summarised in typical records obtained in Nuli-1 and CuFi-3 cell
lines (figure 1A) and NHBE and CFBE primary cultures
(Figure 1B) and on corresponding histograms (Figure 1C). There
was no significant difference in the maximum increase in calcium
induced by LXA4 (100 nM) between non-CF and CF bronchial
epithelial cell lines (Figure 1A and 1C). However the maximum
increase obtained in CF bronchial epithelial primary culture
(CFBE) was significantly higher than in non-CF (NHBE) bronchial
epithelial primary cultures (Figure 1B and 1C). The kinetics of the
Ca
2+ responses were markedly different between CF and non-CF
cells. In the non-CF bronchial epithelial cells (NHBE primary
cultures and Nuli-1 cell line), the intracellular Ca
2+ rise induced by
LXA4 was fast and transient with a recovery to basal values within
2 to 5 min (Figure 1C). In contrast, in the CF bronchial epithelial
cells (CFBE primary cultures and CuFi cell lines), LXA4 induced a
slower increase in Ca
2+ and a delayed (or absent) recovery toward
basal values (Figure 1C). Thus the total amount of Ca
2+ mobilised
in the cytosol upon LXA4 exposure was higher in CF cells than in
non-CF bronchial epithelial cells.
In order to investigate the origin of the calcium signal induced
by LXA4, we tested the effect of LXA4 on intracellular Ca
2+
mobilization in the absence of extracellular Ca
2+ in non-CF and
CF airway epithelial cells. The results presented in Figure 1A show
that in Nuli-1 cells bathed in an external Ca
2+-free solution, the
response to LXA4 was not different from control conditions (plain
line). In Nuli-1 cells, there was no significant difference in the
maximum Ca
2+ increase obtained after LXA4 exposure with or
without external Ca
2+ (F340/F380 : control 8.4960.48 and
external Ca
2+-free 8.5760.32) and in the value measured 2 min
after the peak (5.2260.43 in control condition and 5.8960.36 in
external Ca
2+-free (n=4, p.0.1)). These results indicate that in
normal airway epithelial cells, LXA4 generates a calcium signal
mainly due to the release of Ca
2+ from intracellular stores rather
than Ca
2+ entry. As shown in Figure 1A, there was no difference in
the maximum Ca
2+ increase in CuFi-3 cells obtained after LXA4
exposure with or without external Ca
2+ (F340/F380: control
8.7660.55 and external Ca
2+-free: 8.9960.49 (n=4, p.0.1)).
However, in external Ca
2+-free medium, the calcium response to
LXA4 in CuFi-3 cells was more transient with a rapid recovery to
basal values. The F340/F380 ratio values obtained 2 min after the
peak Ca
2+ response were 7.1760.43 in control conditions and
2.2960.46 (n=4, p,0.05) in an external Ca
2+-free solution.
Taken together, these results suggest that, in CF airway epithelia,
in addition to the Ca
2+ mobilisation from intracellular stores,
LXA4 also stimulates Ca
2+ entry and this response is absent in
non-CF bronchial epithelial cells (Figure 1A).
Role of the ALX/FPR2 Receptor in the Calcium Response
to LXA4
The role of the ALX /FPR2 receptor in the Ca
2+ response to
LXA4 was investigated using the specific inhibitor, Boc-2
(Figure 2). The effect of LXA4 (100 nM) on intracellular Ca
2+
was completely abolished after treatment with Boc-2 (10 mM) in
both NuLi-1 (n=5) and CuFi-3 (n=4) cells (figure 2A and 2B).
However, ATP (100 mM), a known stimulator of intracellular Ca
2+
mobilisation via purinergic receptor stimulation, produced a Ca
2+
signal in cells treated with Boc-2 (Figure 2A). These results support
the involvement of the ALX/FPR2 receptor in the Ca
2+ signalling
response to LXA4.
LXA4 Effects on Whole-cell Currents in Non-CF and CF
Bronchial Epithelial Cells
Since intracellular Ca
2+ is a regulator of Cl
2 transport and we
have shown that LXA4 we regulates Ca
2+, we investigated the
effect of LXA4 on ion transport using whole cell patch-clamp
recording techniques. The whole-cell current-voltage relationships
were obtained from whole-cell patch-clamp recordings in non-CF
(NHBE primary culture and Nuli-1 cell line) and CF (CFBE
primary culture and CuFi-3 cell line) human bronchial epithelial
cells.
As shown from the current-voltage curves (Figure 3 and 4) and
in Table 1, the whole-cell currents under control conditions were
outwardly rectified in non-CF and CF cell lines and in primary
airway epithelial cells. The reversal potentials (Erev) obtained in the
cell lines (Erev Nuli-1=223.863.2 mV, Erev CuFi-3=221.
63.6 mV) and primary cultures (Erev NHBE=222.463.9 mV
and Erev CFBE=222.461.9 mV) indicate that Cl
2
(ECl=239 mV) is the main charge carrier under these conditions
(Table 1).
LXA4 exposure stimulated the whole-cell currents in non-CF
and CF airway epithelial cell lines and in normal and CF primary
cultures, in a time-dependent and dose-dependent manner, as
illustrated in Figure 3 and Figure 4, respectively.
Typical whole-cell current-voltage relationship in NHBE and
CFBE primary cultures recorded over variable duration of LXA4
(100 nM) exposure illustrate the time-dependence of the response
(Figure 3A and 3B). The statistical significance of the time
dependence of current responses have been investigated in non-CF
and CF airway epithelial cell lines and primary cultures as shown
in Figure 3C. The maximum stimulatory effect on the inward
conductance (for outward flux of Cl
2 from the cell) in non-CF
airway epithelial cells (Nuli-1 and NHBE) was obtained after
10 min exposure to LXA4 and declined thereafter to control levels
(Figure 3C). In CF airway epithelial cells (CuFi-3 and CFBE), the
increased inward conductance induced by LXA4 was sustained
without recovery to basal values over the 15 min period of
observation (Figure 3C).
The dose dependence of the response to LXA4 was investigated
in the non-CF and CF cell lines. The stimulatory effect of LXA4
on membrane conductance was found to be dose-dependent as
illustrated on the typical whole-cell current-voltage relationship
obtained from Nuli-1 and CuFi-3 cell lines upon exposure to
different LXA4 concentrations (figure 4A and 4B). In both cell
lines, significant responses were observed at concentrations as low
as 1 pM and the maximum response achieved at 10 nM LXA4
(Figure 4C).
LXA4 Increases Cl- Secretion and ASL in CF Airways
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were significantly increased by LXA4 (100 nM, 10 min) without
any change in the reversal potential in all cell types studied
including primary cultures of CF and non-CF bronchial epithelia
and CF and non-CF cell lines.
Role of the ALX/FPR2 Receptor in the Whole Cell
Conductance Responses to LXA4
The inhibitory effect of the Boc-2 antagonist on calcium
responses to LXA4 indicate a role for the ALX/FPR2 receptor in
transducing LXA4 responses in airway epithelial cells. This is also
true for lipoxin effects on membrane ionic currents where
treatment of Nuli-1 and CuFi-3 cells with Boc-2 (10 mM)
completely abolished the stimulatory effect of LXA4 on the
whole-cell current. As indicated in figure 4C, Boc-2 did not affect
the basal inward conductance but significantly prevented the
increase in inward conductance induced by LXA4 (Figure 4C).
Role of Intracellular Ca
2+ in the Whole-cell Conductance
Responses to LXA4
The role of intracellular Ca
2+ in the LXA4 induced whole-cell
currents was evaluated using BAPTA-AM in the patch pipette as a
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Figure 1. LXA4 effect on intracellular Ca
2+ activity in non-CF and CF bronchial epithelial cells. (A) Typical effect of LXA4 (100 nM) on the
cytosolic Ca
2+ (ratio F340/F380) measured in Nuli-1 and CuFi-3 cell lines in control (plain line) and in external Ca
2+ -free conditions (dotted line). (B)
Typical effect of LXA4 (100 nM) on the cytosolic Ca
2+ in normal and CF primary cultures of bronchial epithelial cells (NHBE and CFBE). (C) Mean values
of the maximum increase in Ca
2+ (peak) and measured 2 and 5 minutes after the peak, in Nuli-1 (n=6), CuFi-1 (n=6), CuFi-3 (n=6), CuFi-4 (n=4) cell
lines and in NHBE (n=4) and CFBE (n=4) bronchial epithelial cells in primary culture (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0037746.g001
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2+. Under these conditions of low
intracellular Ca
2+, the basal whole-cell conductances remained
unchanged, whereas the lipoxin-stimulated currents were absent in
BAPTAM-treated cell. The use of BAPTA-AM demonstrated the
absolute requirement for an increase in intracellular calcium levels
to transduce the effect of LXA4 on whole-cell inward conductance
in both NuLi-1 cells and in CuFi-3 cells (Figure 4C).
LXA4 Effect on Cl
2 Secretion
The contribution of Cl
2 channels to the LXA4 induced current,
was tested using chloride ion channel inhibitors; NPPB (calcium-
activated Cl
2 channel inhibitor) and CFTR-inh172 (CFTR Cl
2
channel inhibitor), and recording their effect on membrane
current and conductance responses to LXA4 in CF and non-CF
cells (Figure 5). Pre-treatment of CFBE primary cultured cells for
2 min with NPPB (1 mM) prior to LXA4 exposure, completely
inhibited the stimulatory effect of LXA4 on whole-cell current
(p.0.5, n=3). Furthermore, the addition of NPPB (1 mM) 10 min
after exposure to LXA4 (100 nM), immediately inhibited the
whole-cell currents in non-CF and CF cells. Figure 5A illustrates a
typical experiment performed in NHBE primary cells showing the
inhibitory effect of NPPB treatment after LXA4 stimulation of the
whole cell currents. A summary of the inhibitory effects of NPPB
on inward conductance in the CF and non-CF primary cultures,
and CF cell line (CuFi-3) are presented in figure 5A. As an
additional proof for the role of Cl
2 channels in driving the LXA4
induced current, we found that in the absence of an electrochem-
ical driving force for chloride ions (equimolar Cl
2 replacement in
the bath and patch pipette), LXA4 did not produce a change in
whole-cell current in any of the cell types tested (data not shown).
The specific CFTR inhibitor, CFTR-inh172, had no effect of
CFTR-inh172 on basal or LXA4-stimulated membrane current
and conductance in CFBE and CuFi-3 cells (data not shown),
consistent with the absence of functional CFTR. Moreover, the
CFTR inhibitor did not affect the stimulation of the whole-cell
current by LXA4 in NuLi-1 cells (Figure 5B). When Nuli-1 cells
were pre-treated with CFTR-inh172 (5 mM), subsequent LXA4
exposure stimulated the outward and inward conductances by
2.160.15 fold and 2.560.14 fold (n=3), respectively (Figure 5B).
These results indicate that the stimulatory effect of LXA4 on
whole-cell current and conductance in non-CF and CF bronchial
cells is mainly due to activation of NPPB-sensitive Cl
2 channels
and does not involve CFTR channels.
LXA4 Effects on Airway Surface Liquid Height
The consequence of LXA4 stimulation of Cl
2 channels and
transepithelial Cl
2 secretion on ASL height was investigated in the
cell lines (Nuli-1, CuFi-1 and CuFi-3) and in primary cultures of
non-CF and CF airway epithelial cells grown on permeable
supports under an air/liquid interface. The ASL measurements
were carried out after a period of 24 hours exposure to apical fluid
(8 ml of PBS) to allow fluid absorption/secretion and ASL height to
reach a steady state. Under control conditions (without LXA4), the
non-CF epithelia from NuLi-1 cell and primary cultures displayed
a continuous unbroken ASL layer (not shown) whereas CF epithelia
from cell lines and primary cultures presented a disrupted and
thinner ASL layer (figure 6). Exposure to LXA4 (100 nM, 15 min)
increased the ASL height in both non-CF and CF cell lines and
primary cultures (figure 6). LXA4 treatment produced a maximum
ASL height increase from 7.2560.07 mm (n=6) to 9.960.1 mm
(n=6) in Nuli-1 epithelia (p,0.001) and from 4.660.20 mm
(n=6) to 11.160.20 mm (n=6) in CuFi-1 epithelia (p,0.001), and
from 6.460.1 mm (n=6) to 9.560.2 mm (n=6) in CuFi-3
epithelia (p,0.001) and from 4.960.32 mm (n=9) to
9.860.10 mm (n=9) in CFBE primary cultures (p,0.001). The
ASL height response to LXA4 obtained in CFBE primary cultures
from 3 different CF patients was found to be robust and similar to
the ASL response obtained in CuFi-1 differentiated cells. In all of
the CF bronchial epithelia, the disrupted appearance of the ASL
layer was absent following LXA4 treatment (Figure 6 B, C, D).
Role of Cl
2 Transport in the ASL Height Responses to
LXA4
The Na/K/2Cl co-transporter inhibitor bumetanide was used
to investigate the contribution of Cl
2 secretion to the generation of
the ASL. Bumetanide (1 mM) treatment significantly decreased the
basal ASL height (control 7.2560.07 mm, bumetanide
5.960.1 mm( p ,0.001, n=6)) in NuLi-1 monolayers but had no
significant effect on ASL height in CuFi-1 epithelia (control
4.660.1 mm, bumetanide 4.8260.10 mm( p .0. 5, n=6)), in CuFi-
3 epithelia (control 6.460.1 mm, bumetanide 6.360.3 mm( p .0.5,
n=6)) and in CFBE (control 4.960.32 mm, bumetanide
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Figure 2. Effect of Boc-2 on the intracellular Ca
2+ signal
induced by LXA4. (A) Representative effect of LXA4 (100 nM) and
ATP (100 mM) on cytosolic Ca
2+ (ratio F340/F380) in NuLi-1 cells in
control conditions (upper panel) and after 24 hours of pre-treatment
with Boc-2 (10 mM) a specific inhibitor of ALX/FPR2 (lower panel). (B)
Mean values corresponding to the effect of Boc-2 on the Ca
2+ response
to LXA4 in Nuli-1 (n=5) and in CuFi-3 (n=4) cell lines (*** p,0.001).
doi:10.1371/journal.pone.0037746.g002
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2
secretion contributes to the generation of the basal ASL height
in the non-CF epithelium. Furthermore, bumetanide (1 mM)
significantly abolished the ASL height increase induced by LXA4
in cell types tested. The ASL height measured after LXA4
exposure in the presence of bumetanide was significantly
decreased in NuLi-1 (5.660.11 mm, n=5, p,0.05), in CuFi-1
(4.8660.1 mm, n=6, p,0.001) and in CuFi-3 (6.260.1 mm,
n=6, p,0.001) cell lines and in CFBE primary cultures
(4.760.2 mm, n=9, p,0.001) compared to LXA4 alone
(Figure 6). Taken together, these results demonstrate that the
stimulatory effect of LXA4 on ASL height mainly involves Ca
2+-
dependent Cl
2 secretion via NPPB-sensitive channels in both CF
and non-CF epithelia grown from cell lines and primary cultures.
Role of the ALX/FPR2 Receptor in the ASL Height
Responses to LXA4
We tested the effect of the ALX/FPR2 receptor antagonist Boc-
2 on the ASL height response to LXA4. Boc-2 significantly
reduced the effect of LXA4 on ASL height in Nuli-1, CuFi-1 and
CuFi-3 bronchial epithelial cell lines and CFBE primary cultures
without affecting the basal ASL height (Figure 6). These data
support the conclusion that the LXA4 receptor ALX/FPR2
mediates the effect of LXA4 on airway surface liquid height as well
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Figure 3. Time dependency of the effect of LXA4 on whole-cell currents in normal and CF bronchial epithelial cells in primary
culture. Typical I-V relationships and corresponding current records obtained before and after 5, 10 and 15 min exposure to LXA4 (100 nM) in NHBE
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2 secretion in bronchial
epithelium.
Discussion
This is the first study to report a novel effect of the endogenous
lipoxin LXA4 to stimulate an increase in Airway Surface Liquid
height, by enhancing Ca
2+ activated Cl
2 transport in bronchial
epithelial cells obtained from patients with CF and non-CF
patients and in airway cell lines.
In the healthy lung, the ASL forms a thin layer of fluid on the
surface of the bronchial epithelium which allows cilia to beat
effectively [8]. Maintenance of an optimal ASL height for ciliary
beat is crucial for the efficacy of mucociliary clearance [8–12].
Bronchial epithelial ion transport regulates the ASL height, mainly
by generating osmotic gradients which provide the driving force
for transepithelial water movement [13]. In CF, the lack of
functional CFTR leads to a reduced ASL height, resulting in an
impaired mucociliary clearance that promotes chronic bacterial
infection of the airways [3]. In a previous study, we reported that
LXA4 stimulated an intracellular Ca
2+ mobilization in a normal
human airway epithelial cell line 16HBE14o- [7]. Here, we tested
the hypothesis that LXA4 induces a Ca
2+ signal to drive an
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(n=3 Nuli-1, n=3 CuFi-3) and 100 nM (n=6 Nuli-1, n=6 CuFi-3) LXA4 in Nuli-1 (A) and CuFi-3 (B) cell lines. (C) Mean inward conductance changes
normalized to control values (gi/gic obtained without LXA4) as a function of LXA4 concentration in Nuli-1 (open bars) and CuFi-3 (black bars) cells in
control conditions and obtained upon exposure to Boc-2 (10 mM) alone (10 min, 100 nM, n=4 Nuli-1, n=4 CuFi-3) or with Boc-2 (10 mM) and LXA4
(10 min, 100 nM, n=6 Nuli-1, n=6 CuFi-3) and after BAPTA-AM pre-treatment alone (n=6 Nuli-1, n=6 CuFi-3) or with BAPTA-AM and LXA4 (10 min,
100 nM, n=4 Nuli-1, n=6 CuFi-3).
doi:10.1371/journal.pone.0037746.g004
Table 1. Mean outward (Gout) and inward (Gin) conductances
and reversal potentials (Erev) measured in non CF and CF
airway epithelial cells in primary culture and NuLi-1 and CuFi-3
cell lines in control conditions and stimulated by LXA4
(100 nM, 10 min).
Gout (pS) Gin (pS) Erev (mV) n
NHBE Control 612.26165.2 227.7699.3 222.463.9 16
LXA4 17426147.2 676636.6 221.465.8 13
CFBE Control 855.46192.9 302.96100.4 222.461.9 8
LXA4 3187.56172.11078.14643.4223.863.1 8
NuLi-1 Control 622.16168.9 298.7685.5 223.863.2 8
LXA4 1365.1675.8 1192624.2 222.963.7 6
CuFi-3 Control 979.66146.8 150661.36 221.763.6 5
LXA4 2156.56232.79996132.97 224.764.0 5
doi:10.1371/journal.pone.0037746.t001
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2 secretion and ASL height in CF epithelium. Lipoxin
A4 thus stimulates a compensatory calcium-activated chloride
secretory mechanism which overcomes the lack of CFTR
mediated Cl
2 transport and enhances airway lumen hydration.
Other studies have shown that LXA4 exerts biological actions
on human airway epithelial cells, with a maximal effect observed
at 100 nM. LXA4 (100 nM) inhibited IL-8 production by airway
epithelial cells [14], stimulated an intracellular Ca
2+ signaling [7],
increased Z0–1 expression and transepithelial electrical resistance
[15], and enhanced epithelial repair after an acid injury [16]. We
report here, novel effects of LXA4 on ion and fluid transport in
normal and CF bronchial epithelia.
Our studies show that LXA4 induces an intracellular Ca
2+
mobilization in normal and CF epithelia. The Ca
2+ response to
LXA4 involves signal transduction via the ALX/FPR2 receptor,
since the FPR2 receptor antagonist Boc-2 inhibited the LXA4
effect. This result supports our previous study which suggested that
the Ca
2+ signal induced by LXA4 was mediated by the ALX/
FPR2 receptor since the Ca
2+ response to LXA4 was only obtained
in the 16HBE14o- airway epithelial cell line that express the
receptor whereas LXA4 did not produce any Ca
2+ response in the
A549 cell line which does not express ALX/FPR2 [7].
Our results indicate that in non-CF airway epithelial cells,
LXA4 generates a rapid and transient calcium signal mainly
arising from the release of Ca
2+ from intracellular stores and not as
a result of increased Ca
2+ entry since the calcium signal was not
affected by the removal of external Ca
2+. This is in agreement with
our previous findings showing that the Ca
2+ mobilization induced
by LXA4 was generated from thapsigargin sensitive stores [7]. In
contrast, in CF airway epithelial cells, the duration of the Ca
2+
signal induced by LXA4 was greater than in non-CF cells.
Although, in CF cells, the removal of external calcium did not
affect the maximum peak calcium increase, the calcium response
to LXA4 became more transient. These results suggest that, in CF
airway epithelial cells, in addition to the calcium release from
intracellular stores, LXA4 also stimulates calcium entry which
leads to an overall larger calcium mobilisation than in normal
airway epithelial cells. The observed differences reported in the
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Figure 5. Effects of Cl
2 channel inhibitors on whole-cell currents stimulated by LXA4. (A) Representative I-V relationship of the effect of
NPPB (1 mM) after the stimulation of primary cultures of bronchial epithelial cells with LXA4 (100 nM). Corresponding histogram of the inhibitory
effect of NPPB on the inward conductance obtained in non-CF primary NHBE cells (n=4), CuFi-3 cells (n=3) and CF primary CFBE cells (n=3) after
stimulation with LXA4 (100 nM, 10 min). (B). Typical I-V relationships of the effect of LXA4 (100 nM) obtained in NuLi-1 cells after treatment with the
CFTR channel inhibition CFTR-inh172 (5 mM) and histogram showing the absence of inhibitory effect in Nuli-1 cells (n=3).
doi:10.1371/journal.pone.0037746.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37746literature between the Ca
2+ signal obtained upon agonist exposure
in CF and non-CF airway epithelial cells are controversial. Some
authors reported that expression of either CFTR or DF508CFTR
in airway epithelial cells had no effect on intracellular Ca
2+ [17].
However, our results are in accordance with the demonstration
that Ca
2+ signaling is abnormal in CF airway epithelial cells and
that correction of the abnormal trafficking of DF508CFTR protein
restored intracellular Ca
2+ homeostasis [18]. Recent reports also
indicate that intracellular Ca
2+ signals induced by pro-inflamma-
tory mediators are increased in CF airway epithelia compared to
non-CF due to an expansion of the apical endoplasmic reticulum
Ca
2+ stores in CF airway epithelial cells [19]. This finding is
Figure 6. LXA4 (100 nM) effects on airway surface liquid height in NuLi-1 (A), CuFi-3 (B) and CuFi-1 epithelial cell line (C) and CFBE
primary cultures (D). Epithelial cells were stained with calcein green, and the ASL labelled with dextran-conjugated Texas red
TM fluorochrome. For
each cell preparation, typical z-plane confocal sections showing ASL responses to LXA4 (top) and mean ASL height changes (bottom) in control
conditions or following LXA4 (100 mM) exposure in NuLi-1,CuFi-3, CuFi-1 and CFBE epithelia treated or not with Boc-2 (10 mM) and with bumetanide
(10 mM).
doi:10.1371/journal.pone.0037746.g006
LXA4 Increases Cl- Secretion and ASL in CF Airways
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37746consistent with several studies showing that the nasal transepithe-
lial electrical potential responses to agents that promote an
intracellular Ca
2+mobilization and Ca
2+-dependent Cl
– conduc-
tance were higher in CF patients than in normal subjects [20–23].
Intracellular Ca
2+ regulates several epithelial functions includ-
ing ion transport, mucin secretion, and ciliary beat frequency
which constitute a primary mode of a non-specific cleansing
process and lung protection. Our results indicate that the Ca
2+
signal induced by LXA4 is coupled to an increased Cl
2 secretion
in CF epithelium. LXA4 stimulated the whole-cell current and
conductance in non-CF and CF epithelial cells. The inhibitory
effect of BAPTA-AM used as a chelator of intracellular Ca
2+
demonstrated the essential role of Ca
2+ in the stimulation of the
whole-cell currents by LXA4. The sensitivity of basal and
stimulated whole-cell currents to NPPB or Cl
2 substitution,
underscores the major contribution of Cl
2 secretion to the
generation of the whole-cell current. These results agree with our
previous report indicating that LXA4 stimulated a Ca
2+-activated
transepithelial Cl
2 secretion in non-CF bronchial epithelial cells
[7]. Since we found that LXA4 stimulation of the whole-cell
currents was present in CF airway epithelia (in which CFTR is not
functionally expressed), LXA4 most probably affects Cl
2 channels
other than CFTR. In addition, we found that the duration of the
LXA4 effect on whole-cell currents was different between non-CF
and CF cells, with a transient current increase in non-CF cells
compared to CF cells where the current increase was more
sustained. One explanation may be that the time course of the
effect of LXA4 on the Cl
2 currents is directly related to the time
course of the intracellular calcium change induced by LXA4.
Therefore, the greater and sustained effect of LXA4 on whole-cell
currents in CF cells could be related to the long lasting Ca
2+ signal
obtained in CF airway epithelial cells. Finally, the ineffectiveness
of CFTR inh-172 on the LXA4 stimulated whole-cell currents
indicates that the effect of LXA4 on Cl
2 secretion is not mediated
by CFTR activation. This conclusion is strengthened by the
observation that bumetanide reduces further the ASL height
compared to Boc-2 treatment in Nuli-1 cells but not in CuFi-3 cells
where functional CFTR is absent. If LXA4 had stimulated CFTR
and Ca
2+-dependent Cl
2 channels together we would expect
equivalent inhibition of ASL height by Boc-2 and bumetanide in
Nuli-1 cells.
We have described a novel stimulatory effect of LXA4 on Cl
2
secretion which produces an increased ASL height in both normal
and CF epithelia. The CF bronchial epithelia generate a thinner
ASL layer than non-CF airway epithelia. This finding is consistent
with the diminished ASL in CF airways reported in the literature
[12]. In addition, we observed that in control conditions, the non-
CF epithelial monolayers showed a continuous ASL layer whereas
in CuFi-1, CuFi-3 cell lines and CFBE primary cultures the liquid
layer was disrupted. The gaps in the airway surface liquid layer
result from localised de-hydration of the ASL. Following LXA4
exposure in CF bronchial epithelia, the ASL height significantly
increased and appeared uniform. The inhibitory effect of
bumetanide indicates that the effect of LXA4 on ASL height is
mainly dependent on stimulation of transpithelial Cl
2 transport.
However, we cannot exclude the possibility that LXA4 can also
exert its action to increase ASL height through the inhibition of
ENaC activity which is known to be stimulated in CF airway and
down-regulated by increased intracellular Ca
2+.
An important outcome of this work is the comparable results
found for LXA4 effects on ASL height in cell lines and primary CF
cultures. We have demonstrated that using thin film airway liquid
cell culture techniques, the NuLi and CuFi cell lines provide a
robust model of airway liquid dynamics. Although ASL volume
measurements have been published for the Calu-3 airway cell line
[24], it is important to distinguish between ASL volume and height
measurements and their meaning for effective mucociliary
clearance. ASL height is the relevant physiological parameter as
it determines the effective beating of cilia which must be covered
to an optimal height with ASL. The volume of ASL on the other
hand may change without revealing the true optimal ASL height
covering the cilia but instead may reflect flooding of the airways
which would also render cilia beat inefficient for mucocilary
clearance. Although the use of primary airway epithelia tissue is
the ideal for research in CF, the access to patient tissue samples,
particularly children with CF and ‘normal’ non-CF controls as in
our study, is non-trivial. The use of particular airway cell lines such
as NuLi and CuFi which in our hands display normal and CF
airway epithelium phenotype to secrete a thin ASL and mucus
provides an additional validated cell model for CF research where
human tissue samples are rare and difficult to obtain for research
purposes.
Taken together, our results provide evidence for a novel role of
LXA4 in stimulating Ca
2+ activated Cl
2 secretion and ASL
generation in CF and non-CF airway epithelium. Thus LXA4 or
its stable analogues may provide a novel therapeutic strategy to
rehydrate the CF airway by modulating ion transport and airway
surface liquid height via pathways which bypass defective CFTR.
Our findings also indicate that the reduced levels of LXA4
observed in CF patients may be an additional contributory
mechanism by which mucociliary clearance is diminished in CF
airways.
Materials and Methods
Cell Culture
For the primary culture of human bronchial epithelium, the
cells were obtained from bronchial brushing specimens obtained
from 6 children (,6 years old) with CF and 5 non-CF controls
through the SHIELD CF study (Study of Host Immunity and
Early Lung Disease in CF). The children with CF were
homozygous for the Phe508del mutation. Local ethics committee
approval for the study was granted and written informed consent
obtained. Bronchial epithelium brushings were washed and
incubated for two hours at room temperature with 250 mg/ml
amphotericin B in Phosphate Buffer Saline (PBS) without calcium
and magnesium. After centrifugation, the pellet was collected and
re-suspended in 500 ml of Bronchial Epithelium Basal Medium
(BEBM, Clonetics, BioWhittaker, San Diego, USA) supplemented
with 0.5 mg/ml human recombinant epidermal growth factor,
7.5 mg/ml bovine pituitary extract, 0.5 mg/ml epinephrine,
10 mg/ml transferrin, 5 mg/ml insulin, 0.1 mg/ml retinoic acid,
6.5 mg/ml triiodothyronine, and 50 mg/ml gentamicin (BD,
Erembodegem, Belgium) and 250 mg/ml amphotericin B (BD,
Erembodegem, Belgium). The explants were plated in a 24 well
plate (Nunc, Roskilde, Denmark) previously coated with a
fibronectin/collagen solution and incubated at 37uCi na
humidified 5% CO2 atmosphere. Twenty four hours after seeding,
the volume of media was adjusted to 400 ml. The cells were
cultured under these conditions for six to nine days (confluence
close to 70%) before splitting. Fibroblasts were removed by 1
minute treatment with trypsin EDTA (Gibco, Invitrogen, Paisley,
UK). Epithelial cells referred in this paper as NHBE (non-CF
bronchial epithelial cells) and CFBE (CF bronchial epithelial cells)
were then trypsinised and re-suspended after centrifugation, in
supplemented BEBM. The cells were seeded at 2500–4000 cells/
cm
2 in flasks (BD, Erembodegem, Belgium).
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by Prof Zabner,University of Iowa, USA. The NuLi-1 cell line was
derived from human airway epithelium of normal genotype,
whereas CuFi-1, Cufi-3 and CuFi-4 cell lines were derived from
CF patients with D508/D508, R553X/D508, and G551D/D508
genotypes respectively. The cell lines were transformed with a RT
component of telomerase and human papillomavirus type 16 E6
and E7 genes [25]. Cells were initially grown to confluency in
flasks using BEBM with EGF, hydrocortisone, bovine pituitary
extract, transferin, bovine insulin, triiodothyronine, epinephrine,
retinoic acid, penicillin-streptomycin (0.025 mg/ml), gentamicin
(0.05 ng/ml), and amphotericin (25 mg/ml).
Airway epithelial cells were plated at 2610
6 cells/cm
2 on
Millicell hanging cell culture inserts (Millipore, Billerica, USA) for
ASL height measurements. All inserts were pre-coated with
collagen type VI and grown in BEGM medium until confluence
was achieved. Once cell confluence was confirmed under visual
inspection, the medium was switched to DMEM/F-12 (Invitrogen,
Auckland, New Zealand) to aid cell differentiation. This medium
was supplemented with Ultroser G (2%, Pall Biospera, Cergy-
Saint-Christophe, France), which enhances ion transport [25], and
penicillin-streptomycin (0.025 mg/ml), gentamicin (0.05 ng/ml),
and amphotericin (25 mg/ml). Medium at the apical aspect was
aspirated every 3–4 days until the establishment of an air-liquid
interface. The basolateral culture medium was replaced every 2–3
days. After 4–6 weeks growth, the cells formed a polarised
confluent monolayer with a high transepithelial electrical resis-
tance (TER) of .700 V/cm
2.
Intracellular Calcium Imaging
Intracellular Ca
2+ was measured by epifluorescence microscopy
aspreviouslydescribed[26].Thehumanairwayepithelialcellswere
cultured on fibronectin-collagen coated (for primary culture cells)
andoncollagenVIcoated(forNuLi-1andCuFi-1cells)glassbottom
dishes(WPI,Stevenage,UK)for6daysuntil70%ofconfluencewas
reached. Cells were loaded with 5 mM of the Ca
2+ -sensitive
fluorescent probe fura-2-acetoxy-methyl ester (fura 2-AM, Invitro-
gen, Auckland, New Zealand) for 30 min, in the dark, at room
temperature(22uC)andwerethenwashedtwiceinHEPES-buffered
Krebs-Henseleit solution (140 mM NaCl, 5 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES, pH 7.4, 280–290 mOs-
mol). The glass bottom dishes covered with the fura 2-AM loaded
epithelial cell monolayer were mounted on the stage of an inverted
microscope equipped for epi-fluorescence (TE-300, Nikon, Bad-
hoeve Dorp, Netherlands). Intracellular Ca
2+ imaging was per-
formed using the Metafluor Imaging System (Universal Imaging
Corporation). The cell preparation was excited alternatively with
monochromatic light at 340 and 380 nm using an Optoscan
monochromator (Cairn Research Ltd, Kent, UK). The emission
fluorescence produced after fura 2-AM excitation was filtered at
512 nm.TheemittedlightimagewasdetectedusingaPhotometrics
CoolSNAP-fx video camera (Roper Scientific, Evry, France)
coupled to the microscope. The fluorescence obtained at each
excitation wavelength (F340 and F380) depended upon the level of
Ca
2+bindingtofura2-AM.Theresultsaregivenasratiometricdata
(F340/F380), or as amplitude of variation compared to the basal
ratio level (DF340/F380).
Whole-cell Patch-clamp Recording
Freshly isolated epithelial cells obtained from 4 non-CF patients
and from 3 CF patients (genotype: DF508/DF508) and from the
NuLi-1 and CuFi-3 cell lines were used for patch-clamp
experiments. The CuFi-1 cells were not used for patch-clamp
experiments since we could not reach a Giga ohm seal with these
cells. Cells were patch-clamped at room temperature (25uC) on an
inverted microscope (TE-300, Nikon, Badhoeve Dorp, Nether-
lands). Patch-pipettes were prepared from soda glass (Vitrex,
Modulhom, Herlev, Denmark), pulled on a programmable puller
(P80/PC, Sutter Instrument Company, USA). The whole-cell
configuration was obtained from cell-attached mode after breaking
the patch membrane by applying a brief negative pressure in the
patch pipette. Whole-cell currents were amplified (Axopatch 200B,
Axon instrument, CA) and digitized using a 16-bit data converter
(Digidata 1322A, Axon instrument, CA) following low pass
filtering at 5 Khz and sampled in real-time. Whole-cell current
voltage (IV) relationships were analysed using Clampfit software
(Axon instrument, CA).
The patch pipette was filled with a ‘‘high K
+ solution’’ at
pH=7.2, 290 mosm: 110 mM K-gluconate, 20 mM NaCl,
1.2 mM KH2PO4, 3.46 mM, 3mM KH2PO4, 5 mM EGTA,
6 mM HEPES, 2.78 mM CaCl2, pH=7.2 adjusted with KOH.
The bathing solution had the following composition:
140 mM NaCl, 5 mM KCl, 6 mM Hepes, 2 mM CaCl2,
1.2 mM KH2PO4, 1.2 mM MgSO4 and pH=7.4. The Nernst
potentials between the patch pipette and bath for K
+ and for Cl
2
were 277 mV and 239 mV, respectively. The access resistance
(Ra) was determined by fitting the current transients produced by a
5mV voltage pulse with a single exponential. The measured Ra
was 5.4360.08V (n=40).
For experiments performed in ‘‘low internal calcium’’, cells
were bathed in Kreb’s solution and the patch pipette contained
100 nM CaCl2 with 5 mM EGTA and 10 mM BAPTA-AM. In
these conditions the free Ca
2+ has been estimated at 1 pM using
the free software WEBMAXC http://www.stanford.edu/ ˜cpatton/
webmaxc/webmaxcS.htm.
Airway Surface Liquid (ASL) Height Measurements
ASL height was measured using a protocol adapted from
Tarran et al. (10), using live-cell confocal fluorescence microscopy.
To label the ASL, 8 ml PBS containing 1 mg/ml Texas redH-
dextran (10 kD; Invitrogen, Auckland, New Zealand) was added
to the apical surface of the well-differentiated airway epithelium.
The epithelial cells were stained using Calcein-AM (5 mM,
Invitrogen, Auckland, New Zealand) dissolved in medium culture
for 30 minutes and introduced to the basolateral compartment of
the insert. The Fluorinet
TM electronic fluid Perfluorocarbon-72
(FC-72, 3M, St Paul, USA) was added to the apical compartment
of the insert at a volume of 0.5 ml. Perfluorocarbon-72 is
immiscible with the ASL and was used to prevent ASL
evaporation on transferring the inserts from the incubator to the
microscope stage and during the confocal scanning experiments.
Epithelia were Z-scanned using a Zeiss LSM 510 Meta using a
40X objective. For each culture insert, 3 different microscope
fields randomly chosen were XZ scanned. In each microscope
field, the ASL height was measured using the Zeiss LSM Image
analyser software (Carl Zeiss Microlmaging GmbH, Germany) in
9 separate regions randomly determined and then averaged. This
method of quantification was carried out after blind analysis
performed by multiple users. The n values referred to the number
of culture inserts tested in a given condition.
Drugs
The lipoxin LXA4 was purchased from Calbiochem. Aliquots of
LXA4 solution (100 mM) in ethanol were stored at 280uC to avoid
degradation of the molecule. The peptide Boc-Phe-Leu-Phe-Leu-
Phe (Boc-2) (Phoenyx pharmaceutical, Belmont, USA) was used as
specific inhibitor of the ALX/FPR2 receptor (11). For these latter
experiments, cells were pre-incubated with 10
25 M Boc-2 for 24
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Netherlands) was used to chelate intracellular Ca
2+ (12). The 5-
Nitro-2-(3-phenylpropylamino) benzoic acid (NPPB, Sigma, USA)
used at 1 mM is an inhibitor of Ca
2+-activated Cl
2 channels (13).
CFTRinh-172 an antagonist of the CFTR channel and bumet-
anide an inhibitor of the NKCC1 co-transporter were supplied by
Sigma (14).
Data Analysis
The intracellular Ca
2+ variations were measured as the
difference between the mean F340/F380 ratio during the 2 min
prior to exposure to LXA4 and the ratio measured at the peak of
the Ca
2+ response and 2 and 5 min after the peak. In each
experiment, the mean ratio was obtained from all cells in the
microscopic field. In whole-cell patch-clamp experiments, con-
ductances were determined by linear regression of the current-
voltage relationship obtained in n cells. For the ASL height
measurements, three confocal image acquisitions were performed
on each culture insert and nine regions of interest were analysed in
the acquisition field using the LSM image browser (Zeiss). Values
were loaded in an Excel spreadsheet and averaged. Mean value
were obtained from n independent experiments. The experiments
were repeated under the same conditions on a minimum of three
different cell passages. Data are presented as the mean 6 S.E.M.
of n experiments. Measures of statistical significance were obtained
using the Student’s t test for paired data. A p value ,0.05 was
deemed to be significant. All statistical operations were performed
using Excel software (Microsoft).
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